PA
BSX icon

Procyon Advisors’s Boston Scientific BSX Stock Holding History

Procyon Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,833
Closed -$1.06M – 601
2026
Q1 		$1.06M Sell
16,833
-45
-0.3% -$3.6K 0.05% 265
2025
Q4 		$1.61M Buy
16,878
+12,841
+318% +$1.26M 0.08% 210
2025
Q3 		$394K Buy
4,037
+796
+25% +$82.4K 0.02% 352
2025
Q2 		$348K Sell
3,241
-1,524
-32% -$154K 0.03% 347
2025
Q1 		$481K Buy
4,765
+2,434
+104% +$245K 0.03% 382
2024
Q4 		$208K Buy
+2,331
New +$205K 0.01% 524
2020
Q3 		– Sell
-455
Closed -$16K – 314
2020
Q2 		$16K Buy
455
+427
+1,525% +$15.4K 0.01% 571
2020
Q1 		$1K Hold
28
– – ﹤0.01% 895
2019
Q4 		$1K Buy
+28
New +$1.17K ﹤0.01% 922

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Procyon Advisors's BSX Position: Q2 2026 in Review

Procyon Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 16,833 shares — an estimated $1.06M sold.

Procyon Advisors first reported a position in BSX in Q4 2019 and held it in 9 quarters. The position peaked at $1.61M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Procyon Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Procyon Advisors sold 16,833 Boston Scientific shares in Q2 2026, an estimated $1.06M.
  • Procyon Advisors first reported a position in Boston Scientific in Q4 2019 and held it in 9 quarters.
  • Procyon Advisors's Boston Scientific position peaked at $1.61M in Q4 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.